Eurofins Advinus has over a decade of drug discovery experience for novel, first-in-class targets as well as fast follow-on targets, and has produced multiple assets that are in preclinical and clinical development. Eurofins Advinus provides services, both stand-alone and fully integrated, in the following areas.

Eurofins Advinus’ discovery services platform provides in-depth expertise and extensive capabilities across multiple therapeutic areas, including Metabolic Disorders, Inflammatory and Autoimmune diseases, Pain, CNS disorders, and Gastro-intestinal disorders.